Skip to main content
Terug
AVAH logo

Aveanna Healthcare Holdings Inc.

Datakwaliteit: 100%
AVAH
NASDAQ Healthcare Medical - Care Facilities
€ 6,62
▲ € 0,01 (0,15%)
Marktkapitalisatie: 1,44B
Dagbereik
€ 6,52 € 6,74
52-Weeksbereik
€ 3,73 € 10,32
Volume
858.328
50D / 200D Gem.
€ 7,85 / € 7,50
Vorige Slotkoers
€ 6,61

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E 6,4 0,2
P/B 7,4 3,0
ROE % 621,9 3,6
Net Margin % 9,3 3,8
Rev Growth 5Y % 9,7 9,9
D/E 6,9 0,2

Koersdoel Analisten

Hold
€ 11,25 +69.9%
Low: € 10,00 High: € 13,00
Forward K/W
11,41
Forward WPA
€ 0,58
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,42B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2029 € 0,76
€ 0,75 – € 0,77
 2,84B 2
FY2028 € 0,69
€ 0,61 – € 0,80
 2,71B 5
FY2027 € 0,62
€ 0,55 – € 0,68
 2,56B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-19 € 0,15 € 0,83 +452,2%
2025-11-06 € 0,08 € 0,15 +87,5%
2025-08-07 € 0,04 € 0,18 +350,0%
2025-05-08 € 0,03 € 0,10 +216,8%
2025-03-13 € 0,00 € 0,05 +1178,8%
2024-11-07 € 0,01 € 0,02 +254,0%
2024-08-08 € 0,00 € 0,01 +150,0%
2024-05-09 -€ 0,05 -€ 0,03 +40,0%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Belangrijkste Punten

Revenue grew 9,73% annually over 5 years — modest growth
ROE of 621,89% indicates high profitability
Debt/Equity of 6,91 — high leverage
Generating 114,79M in free cash flow
P/E of 6,40 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,46%

Groei

Revenue Growth (5Y)
9,73%
Revenue (1Y)20,19%
Earnings (1Y)N/A
FCF Growth (3Y)163,32%

Kwaliteit

Return on Equity
621,89%
ROIC12,94%
Net Margin9,25%
Op. Margin10,91%

Veiligheid

Debt / Equity
6,91
Current Ratio1,32
Interest Coverage1,89

Waardering

P/E Ratio
6,40
Forward P/E11,41
P/B Ratio7,40
EV/EBITDA9,76
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 20,19% Revenue Growth (3Y) 13,31%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9,73% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,43B Net Income (TTM) 225,03M
ROE 621,89% ROA 11,11%
Gross Margin 33,09% Operating Margin 10,91%
Net Margin 9,25% Free Cash Flow (TTM) 114,79M
ROIC 12,94% FCF Growth (3Y) 163,32%
Safety
Debt / Equity 6,91 Current Ratio 1,32
Interest Coverage 1,89
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 6,40 Forward P/E 11,41
P/B Ratio 7,40 P/S Ratio 0,59
PEG Ratio 0,00 Forward PEG N/A
EV/EBITDA 9,76 Fwd EV/EBITDA N/A
Forward P/S 0,60 Fwd Earnings Yield 8,76%
FCF Yield 7,97%
Market Cap 1,44B Enterprise Value 2,59B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,43B 2,02B 1,90B 1,79B 1,68B
Net Income 225,03M -10,93M -134,52M -662,03M -117,04M
EPS (Diluted) 1,05 -0,06 -0,71 -3,57 -0,63
Gross Profit 805,15M 635,54M 595,43M 553,23M 542,40M
Operating Income 265,38M 139,79M 8,07M -642,28M -36,11M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,03B 1,66B 1,61B 1,71B 2,33B
Total Liabilities 1,83B 1,79B 1,74B 1,72B 1,70B
Shareholders' Equity 194,46M -122,09M -127,44M -4,18M 637,95M
Total Debt 1,34B 1,50B 1,50B 1,36B 1,30B
Cash & Equivalents 193,26M 84,29M 43,94M 19,22M 30,49M
Current Assets 560,23M 392,67M 314,89M 269,75M 279,22M
Current Liabilities 424,46M 402,17M 354,76M 326,50M 344,83M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#207 of 619
46

Recente Activiteit

Uitgestapt Contrarian Investing (David Dreman)
Mar 26, 2026
Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026